Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

Jornada de lupus

Cardiovascular risk, key factors in lupus progression and brain fog at the lupus day

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

Dra. Sara Marsal

UCB acquires IMIDomics' patient insights business powered by VHIR's IMID Biobank

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Ponents de la jornada del VHIR i BIOCAT sobre teràpies avançades

Vall d'Hebron and Biocat discuss the clinical development of advanced therapies

The session focused on the scientific, regulatory and clinical challenges of advanced therapy medicinal products, from preclinical research to first-in-human trials.

See more

Related professionals

Maria Elena Ballarin Alins

Maria Elena Ballarin Alins

Research assistant
Clinical Pharmacology
Read more
Micaela Cecilia Abud

Micaela Cecilia Abud

Gestió i Administració
Infrastructure Coordination
Manager
Read more
Katerina Papadakis

Katerina Papadakis

Gestió i Administració
Internal Strategy Directorate
Read more
Gloria Santaliestra Vivaracho

Gloria Santaliestra Vivaracho

Research assistant
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.